FDA Mulls Standards For Neurodiagnostic Tools
This article was originally published in The Gray Sheet
Executive Summary
The noninvasive tests of cognitive functioning hold a great deal of promise, but have not yet been fully validated, experts said at a meeting convened by FDA.